Ontruzant 420 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9LS3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,668
Award facts
- Contract value 100% obligated
- $14,668.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14.67K delivery order to AmerisourceBergen Drug Corp for 420 mg vials of Ontruzant, a trastuzumab biosimilar used in cancer treatment. This non-set-aside, competitively awarded order, issued on January 16, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of January 20, 2026. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and primary distribution hub.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99M through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide, including Defense Health Agency facilities and U.S. Coast Guard medical operations. As a critical pharmaceutical distributor in the federal supply chain, Cencora/AmerisourceBergen regularly fulfills delivery orders for diverse therapeutic domains across the defense medical infrastructure.
Quick answers
Who was awarded contract SPE2DR26F9LS3?
SPE2DR26F9LS3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9LS3 worth?
The government has obligated $14,668 on SPE2DR26F9LS3.
Is contract SPE2DR26F9LS3 an order under another contract?
Yes. SPE2DR26F9LS3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LS3 competed?
The extent of competition for SPE2DR26F9LS3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award